Cathepsin L1

From Cysteinome
Revision as of 20:08, 31 July 2019 by Wu3857 (talk | contribs) (Created page with "{| align="left" | __TOC__ |} {{#invoke:InfoboxforTarget|run|CTSL, CTSL1|[https://www.uniprot.org/uniprot/P07711 P07711]|Homo sapiens|Cys138|[http://pfam.xfam.org/family/PF...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Basic Information
Short Name CTSL, CTSL1
UNP ID P07711
Organism Homo sapiens
Cys Site Cys138
Family/Domain Peptidase C1 family
Known Ligand Ligand list
Function Type Protease

Summary

Protein Function

Important for the overall degradation of proteins in lysosomes. (From Uniprot)
Cathepsin L1 is a lysosomal cysteine protease that plays a major role in intracellular protein catabolism. Its substrates include collagen and elastin, as well as alpha-1 protease inhibitor, a major controlling element of neutrophil elastase activity. Cathepsin L1 has been implicated in several pathologic processes, including myofibril necrosis in myopathies and in myocardial ischemia, and in the renal tubular response to proteinuria. This protein, which is a member of the peptidase C1 family, is a dimer composed of disulfide-linked heavy and light chains, both produced from a single protein precursor. At least two transcript variants encoding the same protein have been found for this gene. CTSL1 has been shown to interact with Cystatin A. (From Wikipedia)

Cys Function & Property

Cys138 is one of the active sites of Cathepsin B, which is very close to His276 and Asn300 in space. These three residues formed a typical catalytic triad motif.

  • Hydrophobic property:
511-hydro.png
  • SASA:
Cys138: 11.897 A^2

Protein Sequence

MNPTLILAAF CLGIASATLT FDHSLEAQWT KWKAMHNRLY GMNEEGWRRA
VWEKNMKMIE LHNQEYREGK HSFTMAMNAF GDMTSEEFRQ VMNGFQNRKP
RKGKVFQEPL FYEAPRSVDW REKGYVTPVK NQGQCGSCWA FSATGALEGQ
MFRKTGRLIS LSEQNLVDCS GPQGNEGCNG GLMDYAFQYV QDNGGLDSEE
SYPYEATEES CKYNPKYSVA NDTGFVDIPK QEKALMKAVA TVGPISVAID
AGHESFLFYK EGIYFEPDCS SEDMDHGVLV VGYGFESTES DNNKYWLVKN
SWGEEWGMGG YVKMAKDRRN HCGIASAASY PTV

Structural Information

  • Known structure with covalent ligand:
3OF8, 3OF9, 2YJC, 2XU1, 2XU3, 2YJB
2YJ9, 2YJ8, 2YJ2, 2XU5, 2XU4, 3HWN
3HHA
  • Protein structure:
511.png

Related Pathway

Experimental Evidence

Crystallography, Homologous Analysis of Sequence, Enzymatic Assay

Reference

  1. Torkar A, Lenarčič B, Lah T, et al. Identification of new peptide amides as selective cathepsin L inhibitors: The first step towards selective irreversible inhibitors?[J]. Bioorganic & medicinal chemistry letters, 2013, 23(10): 2968-2973. 23562595
  2. Respondek T, Garner R N, Herroon M K, et al. Light activation of a cysteine protease inhibitor: caging of a peptidomimetic nitrile with RuII(bpy)2[J]. Journal of the American Chemical Society, 2011, 133(43): 17164-17167. 21973207

Falgueyret J P, Black W C, Cromlish W, et al. An activity-based probe for the determination of cysteine cathepsin protease activities in whole cells[J]. Analytical biochemistry, 2004, 335(2): 218-227. 15556560

  1. Shenoy, R. T. and J. Sivaraman (2011). "Structural basis for reversible and irreversible inhibition of human cathepsin L by their respective dipeptidyl glyoxal and diazomethylketone inhibitors." J Struct Biol 173(1): 14-19. 20850545
  2. Hardegger L A, Kuhn B, Spinnler B, et al. Systematic investigation of halogen bonding in protein–ligand interactions[J]. Angewandte Chemie International Edition, 2011, 50(1): 314-318. 21184410

Hardegger L A, Kuhn B, Spinnler B, et al. Halogen bonding at the active sites of human cathepsin L and MEK1 kinase: efficient interactions in different environments[J]. ChemMedChem, 2011, 6(11): 2048-2054. 21898833

  1. Bethel P A, Gerhardt S, Jones E V, et al. Design of selective cathepsin inhibitors[J]. Bioorganic & medicinal chemistry letters, 2009, 19(16): 4622-4625. 19616430
  2. Asaad N, Bethel P A, Coulson M D, et al. Dipeptidyl nitrile inhibitors of Cathepsin L[J]. Bioorganic & medicinal chemistry letters, 2009, 19(15): 4280-4283. 19515558